Linden Advisors LP Accelerate Diagnostics, Inc Transaction History

Linden Advisors LP

  • $506,000
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.27 - $6.97 $1.3 Million - $2.12 Million
-304,500 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$7.99 - $15.0 $365,486 - $686,145
45,743 Added 17.68%
304,500 $2.53 Million
Q4 2020

Feb 16, 2021
BUY
$7.04 - $11.7 $1.75 Million - $2.9 Million
248,150 Added 2339.49%
258,757 $1.96 Million
Q2 2020

Aug 14, 2020
BUY
$7.49 - $15.16 $79,446 - $160,802
10,607 New
10,607 $161,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Linden Advisors LP Portfolio

Follow Linden Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Linden Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email